FDA Issues Safety Announcement For Antipsychotic Medication SAPHRIS
The antipsychotic drug Saphris (asenapine maleate) was approved by the FDA (U.S. Food and Drug Administration) on August 13, 2009. Saphris is an atypical antipsychotic medication used to treat the symptoms of schizophrenia and bipolar disorder. From its FDA-approval in August, 2009 to June, 2011, a[...]